全文获取类型
收费全文 | 71812篇 |
免费 | 5372篇 |
国内免费 | 2018篇 |
专业分类
耳鼻咽喉 | 466篇 |
儿科学 | 1101篇 |
妇产科学 | 521篇 |
基础医学 | 5431篇 |
口腔科学 | 1154篇 |
临床医学 | 9470篇 |
内科学 | 9755篇 |
皮肤病学 | 425篇 |
神经病学 | 3194篇 |
特种医学 | 1864篇 |
外国民族医学 | 2篇 |
外科学 | 6673篇 |
综合类 | 13021篇 |
现状与发展 | 5篇 |
预防医学 | 6169篇 |
眼科学 | 2768篇 |
药学 | 10079篇 |
200篇 | |
中国医学 | 6278篇 |
肿瘤学 | 626篇 |
出版年
2024年 | 229篇 |
2023年 | 1094篇 |
2022年 | 2236篇 |
2021年 | 3187篇 |
2020年 | 2781篇 |
2019年 | 2064篇 |
2018年 | 2062篇 |
2017年 | 2243篇 |
2016年 | 2363篇 |
2015年 | 2331篇 |
2014年 | 4818篇 |
2013年 | 5207篇 |
2012年 | 4376篇 |
2011年 | 4757篇 |
2010年 | 3575篇 |
2009年 | 3214篇 |
2008年 | 3373篇 |
2007年 | 3612篇 |
2006年 | 2990篇 |
2005年 | 2502篇 |
2004年 | 2169篇 |
2003年 | 1742篇 |
2002年 | 1532篇 |
2001年 | 1431篇 |
2000年 | 1181篇 |
1999年 | 1087篇 |
1998年 | 937篇 |
1997年 | 904篇 |
1996年 | 807篇 |
1995年 | 835篇 |
1994年 | 759篇 |
1993年 | 685篇 |
1992年 | 664篇 |
1991年 | 586篇 |
1990年 | 536篇 |
1989年 | 480篇 |
1988年 | 484篇 |
1987年 | 434篇 |
1986年 | 402篇 |
1985年 | 442篇 |
1984年 | 382篇 |
1983年 | 229篇 |
1982年 | 329篇 |
1981年 | 235篇 |
1980年 | 205篇 |
1979年 | 180篇 |
1978年 | 159篇 |
1977年 | 96篇 |
1976年 | 86篇 |
1975年 | 54篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
941.
942.
Solveig R. M. Johansson R. G. G. Andersson 《Naunyn-Schmiedeberg's archives of pharmacology》1981,316(2):190-193
Summary Diazoxide significantly decreased the blood pressure and relaxed the uterine muscle in anaesthetized normotensive rats. A marked elevation of blood glucose followed the intravenous injection of diazoxide. The hyperglycemic and the uterine relaxing response could be significantly decreased by injection of propranolol prior to diazoxide. The hypotensive effect was not diminished by propranolol, however. In liver and uterus the content of cAMP was increased following diazoxide treatment in vivo. The rise in cAMP could be completely inhibited by propranolol, indicating a -receptor stimulation being the cause of the cAMP elevation. 相似文献
943.
T. Kawasaki K. Uezono I. Abe S. Nakamuta M. Ueno N. Kawazoe T. Omae 《European journal of clinical pharmacology》1981,20(6):399-405
Summary To determine whether E-643, a new -blocking agent, would reduce the blood pressure, regardless of the posture, a 1 mg dose was given 3 times daily for 7 consecutive days, to 8 male and 7 female inpatients, aged 37–73 years, with essential hypertension. Blood pressure and pulse rate were measured daily in the supine, sitting and standing positions. Before and after the treatment with E-643, plasma levels of noradrenaline, adrenaline, dopamine--hydroxylase, renin and aldosterone were determined, samples being obtained with the subjects recumbent and after standing upright for 60 min. A significant reduction in the systolic and diastolic blood pressures was evident in the supine (172±31/100±12 151±28/89±14 mmHg), sitting (158±22/101±11 138±28/89±15 mmHg) and standing (153±32/103±21 129±31/89±20 mmHg) positions. The reduction in blood pressure remained unchanged throughout the period of administration of E-643. Pulse rate was not affected when the subjects were supine (67±10 69±10 beats/min), but was increased in the sitting (68±10 73±9 beats/min) and standing (73±10 81±11 beats/min) positions. The increased pulse rate tended to decline during continued administration of E-643. Treatment with E-643 produced no significant change in plasma levels of adrenaline, noradrenaline, dopamine--hydroxylase, renin and aldosterone. The antihypertensive effect of treatment was more prominent in the patients with higher levels of plasma catecholamines and dopamine--hydroxylase, and was less prominent in those with higher plasma renin and aldosterone. Two patients had temporary bouts of dizziness and visual disturbances, but there were no subjective complaints during treatment. 相似文献
944.
Summary Application of paraoxon into the left vertebral artery (8–80 g) or both the left and right vertebral artery (4–8 g) of the anaesthetized cat evoked dose-dependent depressor effects, whereas heart rate was not influenced significantly. Also after systemic administration of paraoxon (150–825 g·kg–1), while peripheral muscarinic receptors were blocked, depressor effects were still observed. Dose-response curves for the depressor response to paraoxon were established. Infusion of low doses of dexetimide via the vertebral artery prevented the hypotensive action of paraoxon. The distribution of this antimuscarinic drug in the brain was investigated. The depressor effect of paraoxon can be attributed to both a decrease in peripheral resistance and cardiac output. Decerebration and midcollicular transection were carried out in order to elucidate the site and mechanism of action. The depressor effect of paraoxon seems to be mediated by a central mechanism of action located within the lower brain stem.It is concluded that stimulation of muscarinic receptors in the pontomedullary region gives rise to the observed changes in haemodynamic parameters. Muscarinic receptors in the hypothalamus seem to be of minor importance for the hypotensive action of paraoxon. 相似文献
945.
In a multicentre clinical trial thirteen patients with primary open angle glaucoma or ocular hypertension were followed during at least six months while selfinstilling Pilogel (once daily) and topical -blocker (twice daily). After six months of combination therapy there was an average decrease in intra-ocular pressure (IOP) of 33.6% 9.5 hours after Pilogel administration and an IOP decrease of 23.4% 22.5 hours after Pilogel administration. With topical -blocker alone, an average IOP decrease of 15% was measured. Throughout the study we observed in six patients (46.1%) a superficial punctate keratitis which mostly spontaneously cleared. We did not see any serious side-effects after six months of combination therapy. 相似文献
946.
P. Ferrari D. Giachino P. Weidmann S. Shaw W. Riesen N. Neuner U. Keller G. Heynen 《European journal of clinical pharmacology》1991,41(2):109-113
Summary The sensitivity of peripheral tissues to insulin is of pathophysiological, therapeutic and possibly also of prognostic relevance. Calcium channel blockers are widely used in the treatment of cardiovascular disorders that are commonly associated with decreased insulin sensitivity (SI). To evaluate the effects of calcium channel blokkade on SI, glucose homoeostasis and lipid profiles, studies were made of SI (determined by the Minimal Model Method of Bergman), basal glucose and insulin levels, serum total triglyceride (Tg) and lipoprotein cholesterol (C) fractions and certain other variables in 38 healthy young men (24 y) during placebo and after 3 weeks of calcium channel blockade with amlodipine 5 mg once daily. Measurements were made after 3 days on a standard diet (2200 kcal · day–1, 45% carbohydrates, 40% fat and 15% proteins) and after an overnight fast. Compared to placebo, amlodipine decreased supine systolic blood pressure (P<0.01). Heart rate, body weight and 24 h urinary sodium excretion were unaltered, and so were fasting plasma glucose (placebo vs amlodipine: 4.86 vs 4.83 mmol·1–1, respectively) and insulin levels (7.7 vs 7.9 U·ml–1), SI (10.5 vs 9.6·10–4 × min–1 pro U·ml–1), serum total Tg, C and lipoprotein C fractions.The findings demonstrate unchanged insulin sensitivity and secretion, as well as lipoprotein regulation, during maintenance administration of 5 mg amlodipine daily to healthy young men.This work was supported in part by the Swiss National Science Foundation 相似文献
947.
Summary Six normal volunteers were studied on four separate occasions. On each occasion they received two concomitant infusions which were either placebo/placebo, placebo/tyramine, angiotensin II/placebo or angiotensin II/tyramine. Angiotensin II infusion was given at a constant rate of 2ng/kg/min whereas the tyramine infusion consisted of 10 min increments at 1.25, 2.5, 3.75, 5, 7.5 and 10 g·kg–1·min–1.Tyramine infusion caused a dose dependent increase in systolic blood pressure with increases in diastolic blood pressure and plasma noradrenaline only at the highest doses. These changes were not affected by concomitant angiotensin infusion.We have therefore found no evidence to support the enhancement of haemodynamic or plasma noradrenaline responses to tyramine infusion by low dose infusion of angiotensin II in man. 相似文献
948.
T. M. MacDonald 《European journal of clinical pharmacology》1991,40(3):225-230
Summary The effects of oral doses of the dopamine antagonist antiemetics metoclopramide and domperidone on baseline and dopamine stimulated renal function and systemic haemodynamics were assessed in a placebo controlled crossover study in 9 healthy volunteers.Metoclopramide did not change baseline ERPF, GFR or FF over 2 h post dosing but it significantly reduced baseline UNaV, UKV, urine flow, urinary dopamine excretion, supine and erect diastolic blood pressure and supine systolic blood pressure. Domperidone and placebo did not cause these effects.Metoclopramide caused a marked rise and domperidone a small fall in plasma aldosterone concentration (PAC) but placebo was without effect. Neither antiemetic altered plasma renin activity (PRA) but a small fall occurred with placebo.Two hours after pretreatment with placebo dopamine (2 g/kg/min) increased effective renal plasma flow (ERPF), glomerular filtration rate (GFR), sodium excretion rate (UNaV), urine flow rate, urinary dopamine excretion rate, supine systolic blood pressure and supine and erect pulse rate and decreased the potassium excretion rate (UKV), filtration fraction (FF) and supine diastolic blood pressure.Metoclopramide pretreatment, did not attenuate the dopamine induced rise in ERPF, GFR, urine flow, urinary dopamine excretion or supine systolic blood pressure but it did attenuate the rise in pulse rate, the fall in diastolic pressure, and the antikaliuretic effect of dopamine leading to a net kaliuresis when compared to placebo. Domperidone was similar to placebo.Neither metoclopramide nor domperidone given orally caused clinically important antagonism of the renal haemodynamic effects of dopamine. However the effects of metoclopramide on blood pressure and electrolyte excretion may have clinical importance.Metoclopramide has significant pharmacodynamic effects which are probably not due to DA2 antagonism but may be mediated by DA1 antagonism or be non-specific.Abbreviations DA
dopamine
- ERPF
effective renal plasma flow
- FF
filtration fraction
- GFR
glomerular filtration rate
- PAC
plasma aldosterone concentration
- PRA
plasma renin activity
- UV
urine flow rate
- UNaV
urinary sodium excretion rate (natriuresis)
- UKV
urinary potassium excretion rate (kaliuresis)
- HPLC
high performance liquid chromatography. 相似文献
949.
N. Singewald A. Pfitscher A. Philippu 《Naunyn-Schmiedeberg's archives of pharmacology》1992,345(2):181-186
Summary Inactivation of GABA was inhibited by -vinyl GABA (GVG) and the effects of the increased GABA level in the brain on blood pressure and body weight of spontaneously hypertensive rats (SHR) and normotensive rats (WKY) were investigated.When started at the age of 8 weeks or 5 weeks, treatment of SHR and WKY with GVG (150 mg/kg, s.c.) for several weeks did not influence systolic blood pressure. In 1-week old SHR, treatment with GVG (up to 150 mg/kg, s.c.) abolished the rise in blood pressure until animals were 8 weeks old. Thereafter, arterial blood pressure started to increase but it remained distinctly lower than that in untreated animals. When started at the age of 1 week, treatment with GVG for 7 weeks did not influence arterial blood pressure in WKY. GVG delayed increase in body weight in SHR and WKY, irrespective of their age. GVG greatly increased GABA levels in the hypothalamus, frontal cortex, brainstem and rest of the brain in both WKY and SHR.It is concluded that an increase in the GABA level in the brain leads to a delay in the development of hypertension in young SHR. Hence, development of genetic hypertension seems to be susceptible to activation of the GABAergic system in a very early critical phase only.
Send offprint requests to N. Singewald at the above addressThis work was supported by the Fonds zur Förderung der wissenschaftlichen Forschung 相似文献
950.
John H. Krystal Christopher J. McDougle Scott W. Woods Lawrence H. Price George R. Heninger Dennis S. Charney 《Psychopharmacology》1992,108(3):313-319
The effects of oral administration of the 2 adrenergic receptor antagonists idazoxan (20 mg, 40 mg, 80 mg) and yohimbine (20 mg) were compared using a placebo-controlled within-subjects design. Healthy subjects completed 5 test days during which medication effects on mood and anxiety states, physiologic indices, plasma cortisol levels, and plasma levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) were assessed. Idazoxan dose-dependently increased plasma MHPG, plasma cortisol, systolic and diastolic blood pressure, and Panic Attack Symptom Scale scores in healthy subjects. Overall, yohimbine and idazoxan produced a similar pattern of behavioral and neuroendocrine responses. Since idazoxan possesses relatively greater receptor specificity compared to yohimbine, it may be a more useful 2 antagonist in humans. 相似文献